Position history for BAKER BROS. ADVISORS LP's holdings in KYMERA THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 8.7M shares of KYMR (KYMERA THERAPEUTICS INC), worth $721.1M as of 2026-Q1. KYMR represents 4.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$721.1M
Current Shares
8.7M
Total Value Change
+$542.1M
Total Shares Change
+2.7M
Other major holders of KYMR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 8.7M |
0.0% |
| $721.1M |
| 4.1% |
| $86.35 |
0 |
| 2025-Q4 | Increased | 8.7M | +30.2% | $673.6M | 3.9% | $78.12 | 73 |
| 2025-Q3 | Unchanged | 6.7M | 0.0% | $376.5M | 2.7% | $58.50 | 0 |
| 2025-Q2 | Increased | 6.7M | +10.9% | $290.3M | 2.8% | $44.12 | 59 |
| 2025-Q1 | Unchanged | 6M | 0.0% | $164.1M | 1.8% | $29.62 | 0 |
| 2024-Q4 | Unchanged | 6M | 0.0% | $241.2M | 2.6% | $39.32 | 0 |
| 2024-Q3 | Increased | 6M | 0.0% | $283.8M | 2.9% | $48.69 | 53 |
| 2024-Q2 | Unchanged | 6M | 0.0% | $179M | 2.3% | $29.85 | 0 |